Nephros (NasdaqCM:NEPH) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker3Good afternoon, everyone, and welcome to the Nephros, Inc. fourth quarter 2025 financial results conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then one on your touchtone telephones. To w ...

The Beauty Health Company (NasdaqCM:SKIN) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker7day, and welcome to The Beauty Health Company 2025 fourth quarter earnings conference call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch tone phone. To withdraw your ...

Capricor Therapeutics (NasdaqCM:CAPR) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker10Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics fourth quarter and full year 2025 conference call. At this time, all participants are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call may be recorded today, Thursday, Mar ...

KORU Medical Systems (NasdaqCM:KRMD) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker7Greetings, and welcome to the KORU Medical Systems fourth quarter 2025 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Louisa Smith, Investor Rela ...

Inovio Pharmaceuticals (NasdaqCM:INO) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker5Afternoon, ladies and gentlemen, and welcome to the Inovio fourth quarter and full year 2025 financial results conference call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, March 12, 2026. ...

Financial Data and Key Metrics Changes - For Q4 2025, total revenues were $2.2 million, a 76% increase from $1.3 million in Q4 2024, primarily due to higher unit sales of M400 smart glasses and increased engineering services sales [20] - For the full year 2025, total revenues were $6.3 million, up 9% from $5.8 million in 2024 [21] - The overall gross loss for 2025 was $1.1 million, significantly improved from a loss of $5.6 million in 2024, mainly due to lower inventory obsolescence reserves [22] - The net loss attributable to common shareholders for Q4 2025 was $8.7 million or $0.12 per share, compared to a net loss of $13.7 million or $0.16 per share in Q4 2024 [26] - For the full year 2025, the net loss was $32.3 million or $0.42 per share, down from $73.5 million or $1.08 per share in 2024 [27] Business Line Data and Key Metrics Changes - Product sales increased by 4% year-over-year, driven by greater unit sales of M400 products [22] - Engineering services sales for 2025 were $1.6 million, up 27% from $1.3 million in 2024 [22] - Research and development expenses rose 31% to $12.6 million in 2025, primarily due to increased external development costs for the new LX1 smart glasses [23] Market Data and Key Metrics Changes - The enterprise markets are becoming more mature and ROI-driven, with customers focused on solutions that improve workflow efficiency and enhance safety [17] - The defense and security agencies segment is seeing growth in active programs and discussions, with a mix of activities including active deliveries and contracted programs [12] Company Strategy and Development Direction - The company is focusing on its OEM products and waveguide technology as key growth engines, with a strategic shift towards more selective investment in branded products [6][9] - The long-term growth strategy is centered around engineering services, with an emphasis on partnerships and customized solutions for large-scale enterprises [8] - The company aims to leverage its waveguide technology for scalable production, positioning itself in the next generation of AI and AR-enabled smart glasses [8][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth of the OEM business and waveguide technology, expecting revenues from these areas to surpass those from the branded enterprise side by the end of 2026 [33] - The company anticipates multiple new business partnerships and orders throughout 2026, indicating a strong pipeline of opportunities [35] - Management highlighted the importance of strategic relationships and the value created through improved business structure and operational capabilities [41] Other Important Information - The company ended 2025 with a cash position of $21.2 million, an increase from $18.2 million in 2024, and no current or long-term debt [27][28] - Inventory levels improved, with net inventory declining to $2.2 million as of December 31, 2025, compared to $4.8 million at the end of 2024 [28] Q&A Session Summary Question: Expectations for 2026 revenue and significant revenue sources - Management expects the OEM and waveguide business to grow quarter after quarter, potentially surpassing revenues from the branded enterprise side by year-end [33] Question: Anticipation of additional orders and announcements in 2026 - Management indicated that there would likely be several announcements regarding orders and partnerships throughout 2026, contributing to new business opportunities [35]

Limoneira Company (NasdaqGS:LMNR) Q1 2026 Earnings call March 12, 2026 04:30 PM ET Speaker5Good evening, and welcome to Limoneira's first quarter 2026 financial results conference call. At this time, all participants are on a listen-only mode. A brief question-and-answer session will follow the formal presentation. It is now my pleasure to introduce your host, John Mills with ICR. Thank you. You may begin.Speaker3Great. Thank you. Good afternoon, everyone, and thank you for joining us for Limoneira's first ...

Universal Electronics (NasdaqGS:UEIC) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker0Good afternoon. My name is Daniel, and I will be your conference operator today. Now I would like to welcome everyone to Universal Electronics fourth quarter and year-end 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question at that time, please press s ...

El Pollo Loco (NasdaqGS:LOCO) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker6Good day, ladies and gentlemen, and thank you for standing by. Welcome to the El Pollo Loco fourth quarter 2025 earnings conference call. At this time, all participants have been placed in a listen-only mode, and there will be an opportunity to ask questions following the presentation. Please note that this conference is being recorded today, March 12, 2026. Now I would like to turn the conference over to Ira Fils, the co ...

Shimmick (NasdaqCM:SHIM) Q4 2025 Earnings call March 12, 2026 04:30 PM ET Speaker4Good afternoon, and thank you all for joining us on today's call. I'm joined by Todd Yoder, Shimmick's CFO. Before I get started, I would like to recognize the women and men who work at Shimmick, safely and effectively delivering the projects we take on as good stewards of the communities where we work. Our work is supporting our nation's infrastructure, and we are all very proud of it. With that, I'm going to start by discuss ...